PINK1 and Parkinson disease: In a zebrafish model of PD, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration inhibited mitochondrial complex I and blocked PINK1 function, leading to the accumulation of damaged mitochondria and the development of motor impairment symptoms in the embryos.